The European Medicines Agency on Thursday declared that the COVID-19 developed by AstraZeneca and Oxford University is "safe and effective," giving a nod of approval for European nations to resume using the inoculation.
Why it matters: It comes after vaccination was halted across much of Europe, following reports that a small number of patients who received the vaccine experienced blood clots. EMA Executive Director Emer Cooke said Thursday the vaccine benefits "outweigh the possible risks."
